Quest Diagnostics IncDGX
Price$231.09Intrinsic value$158.2632% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $158.26median of 6 methods · middle span $142-$326based on filings through 30 Jun 2026
Market Price $231.09Price as of 1 Oct 2026
Margin of Safety -31.5%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 7.5% (near-term consensus, capped) · years 2–5: 10.6%/yr (balance of the path).10.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.6%Yr 78.6%Yr 87.6%Yr 96.7%Yr 105.7%
10.6% → 5.7%
Years 11–20: glide to long-run rate
Per-year rates
Yr 115.4%Yr 125.1%Yr 134.9%Yr 144.6%Yr 154.3%Yr 164.1%Yr 173.8%Yr 183.5%Yr 193.3%Yr 203.0%
5.7% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)5.7%
Discount rate (cost of equity) 8.1%
Volatility vs market (adjusted beta)0.71

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetQuest Diagnostics IncDGXHealth Care
Valuation
P/E24.5×
P/S2.4×
P/B3.7×
EV / Revenue2.8×
EV / EBITDA10.3×
Profitability
Gross margin—
Operating margin13.8%
Net margin9.2%
FCF margin11.7%
Returns
ROE14.1%
ROA6.3%
ROIC8.5%
Growth
Revenue growth (YoY)17.1%
5-yr fwd EPS growth10.0%
Financial strength
Debt / Equity0.75×
Current ratio1.59×
Altman Z-Score3.6
Interest coverage—
Dividend yield1.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.